Effects of place or neighborhood—locations where individuals reside, shop, recreate, and work—have been widely studied as sources of environmental influences on individual behaviors, exposures, and physiology, as well as reference points for public health interventions. However, despite modern prisons' strong influence on the transmission and clinical outcomes of infectious diseases, custodial authorities and public health officials in many countries have yet to implement credible interventions to minimize the adverse impacts prison settings exert on the epidemiology of communicable diseases—particularly with respect to inmates. Among many vulnerable populations, prisons are evolving as one of the social institutions that determine their health status and health outcomes. This article highlights the effects of prisons in mediating the risk of hepatitis C virus and tuberculosis infections, as well as feasible interventions and policy approaches for limiting the deleterious consequences prisons exert on the transmission and clinical courses of these diseases.
WacquantL. Deadly symbiosis: When ghetto and prison meet and mesh. In: GarlandD, editor. Mass imprisonment: Social causes and consequences. London: Sage; 2001. p. 82–120.
de ViggianiN. Unhealthy prisons: Exploring structural determinants of prison health. Sociol Health Ill2007;29:115–35.
9.
RouxAVD. Investigating neighborhood and area effects on health. Am J Public Health2001;91:1783–9.
10.
World Health Organization. Closing the gap in a generation: Health equity through action on the social determinants of health. Final report of the Commission on Determinants of Health. Geneva: WHO; 2008.
11.
BaillargeonJBlackSAPulvinoJDunnK. The disease profile of Texas prison inmates. Ann Epidemiol2000;10:74–80.
12.
SenokACBottaGA. Human immunodeficiency virus and hepatitis virus infection in correctional institutions in Africa: Is this the neglected source of an epidemic?J Med Microbiol2006;55:481–2.
13.
MarquartJWMerianosDEHebertJLCarrollL. Health conditions and prisoners: A review of research and emerging areas of inquiry. Prison J1997;77:184–208.
14.
ValwaySEGreifingerRBPapaniaMKilburnJOWoodleyCDiFerdinandoGT. Multidrug-resistant tuberculosis in the New York State prison system, 1990–1991. J Infect Dis1994;170:151–6.
15.
FreudenbergN. Adverse effects of US jail and prison policies on the health and well-being of women of color. Am J Public Health2002;92:1895–9.
16.
ButlerTPapanastasiouC. National prison entrants' bloodborne virus and risk behaviour survey report—2004 and 2007: Prevalence of HIV, hepatitis C, hepatitis B, and risk behaviours among Australian prison entrants. Sydney: National Drug Research Institute, National Centre in HIV Epidemiology and Clinical Research; 2008.
17.
RaphaelD, editor. Social determinants of health: Canadian perspectives. 2nd ed.Toronto: Canadian Scholars' Press Inc.; 2008.
18.
Butler-JonesD. The Chief Public Health Officer's report on the state of public health in Canada 2008: Addressing health inequalities. Ottawa: Public Health Agency of Canada; 2008.
19.
GaleaSVlahovD. Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarceration. Public Health Rep2002;117(Suppl 1):S135–45.
20.
SolzhenitsynAI. The Gulag archipelago, 1918–1956: An experiment in literary investigation (volume 1). London: HarperCollins; 2007 [original English translation published in 1973].
21.
SmithC. “Healthy prisons”: A contradiction in terms?Howard J Crim Just2002;39:339–53.
22.
National Commission on Correctional Health Care. The health status of soon-to-be-released inmates: A report to Congress (volumes 1 and 2). Chicago: NCCHC; 2002.
23.
GolembeskiCFulliloveR. Criminal (in)justice in the city and its associated health consequences. Am J Public Health2008;98(Suppl 9):S185–90.
24.
AwofesoN. Why fund smoking cessation programmes in prisons?BMJ2005;330:852.
25.
JurnikNC. Individual and organizational determinants of correctional officer attitudes toward inmates. Criminology1985;23:523–39.
26.
WobeserWLDatemaJBechardBFordP. Causes of death among people in custody in Ontario, 1990–1999. CMAJ2002;167:1109–13.
27.
AwofesoN. Prisoner healthcare co-payment policy: A cost-cutting measure that might threaten inmates' health. Appl Health Econ Health Policy2005;4:159–64.
28.
RestumZG. Public health implications of substandard correctional health care. Am J Public Health2005;95:1689–91.
29.
KariminiaAButlerTGCorbenSLevyMGrantLKaldorJ. Extreme cause-specific mortality in a cohort of adult prisoners—1988 to 2002: A data-linkage study. Int J Epidemiol2007;36:310–6.
30.
BinswangerIASternMFDeyoRAHeagertyPJCheadleAElmoreJG. Release from prison—a high risk of death for former inmates. N Engl J Med2007;356:157–65.
31.
VergerPRotilyMPrudhommeJBirdS. High mortality rates among inmates during the year following their discharge from a French prison. J Forensic Sci2003;48:614–6.
32.
LanganPALevinDJ. Recidivism of prisoners released in 1994. Bureau of Justice Statistics special report (NCJ 193427). Washington: Department of Justice (US); 2002.
33.
KriegAS. Aboriginal incarceration: Health and social impacts. Med J Aust2006;184:534–6.
34.
PettitBWesternB. Mass imprisonment and the life course: Race and class inequality in U.S. incarceration. Am Sociol Rev2004;69:151–69.
35.
GarlandD. The meaning of mass imprisonment. Punishm Soc2001;3:5–7.
36.
LavanchyD. The global burden of hepatitis C. Liver Int2009; 29(Suppl 1):74–81.
37.
CrippinJSMcCashlandTTerraultNSheinerPCharltonMR. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantation. Liver Transpl2002;8:350–5.
38.
National Centre in HIV Epidemiology and Clinical Research. HIV/ AIDS, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report, 2001. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2001.
39.
KimWR. The burden of hepatitis C in the United States. Hepatology2002;36(5Suppl 1):S30–4.
40.
AwofesoN. Hepatitis C virus infection: A disease of poverty. Trop Doct2001;31:184.
41.
ParisJPradhamMMAllenSCassidyWM. Cost of hepatitis C treatment in the correctional setting. J Correct Health Care2004;11:199–212.
42.
HilsabeckRCHassaneinTICarlsonMDZieglerEAPerryW. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc2003;9:847–54.
43.
MillerERBiPRyanP. Hepatitis C virus infection in South Australian prisoners: Seroprevalence, seroconversion, and risk factors. Int J Infect Dis2009;13:201–8.
44.
ButlerTKariminiaALevyMKaldorJ. Prisoners are at risk for hepatitis C transmission. Eur J Epidemiol2004;19:1119–22.
45.
MaherLJalaludinBChantKGJayasuriyaRSladdenTKaldorJM. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction2006;101:1499–508.
46.
CroftsNStewartTHearnePPingXYBreshkinAMLocarniniSA. Spread of bloodborne viruses among Australian prison entrants. BMJ1995;310:285–8.
47.
AllwrightSBradleyFLongJBarryJThorntonLParryJV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: Results of a national cross sectional survey. BMJ2000;321:78–82.
48.
van BeekIDwyerRDoreGJLuoKKaldorJM. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study. BMJ1998;317:433–7.
49.
GuimarãesTGranatoCFVarellaDFerrazMLCasteloAKallásEG. High prevalence of hepatitis C infection in a Brazilian prison: Identification of risk factors for infection. Braz J Infect Dis2001;5:111–8.
50.
NunnAZallerNDickmanSTrimburCNijhawanARichJD. Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey. Drug Alcohol Depend2009;105:83–8.
51.
SykesGM. The society of captives: A study of a maximum security prison. Princeton (NJ): Princeton University Press; 1958.
52.
ButlerTBoonwaatLHailstoneSFalconerTLemsPGinleyT. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey. Aust N Z J Public Health2007;31:44–50.
53.
AdjeiAAArmahHBGbagboFAmpofoWKQuayeIKEHesseIF. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawan and Accra, Ghana. J Med Microbiol2006;55:593–7.
54.
HolsenDSHarthugSMyrmelH. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Eur J Clin Microbiol Infect Dis1993;12:673–6.
55.
FoxRKCurrieSLEvansJWrightTLToblerLPhelpsB. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis2005;41:177–86.
56.
RischitelliGHarrisJMcCauleyLGershonRGuidottiT. The risk of acquiring hepatitis B or C among public safety workers: A systematic review. Am J Prev Med2001;20:299–306.
57.
CroftsN. A cruel and unusual punishment. Med J Aust1997;166:116.
LaumannAEDerickAJ. Tattoos and body piercings in the United States: A national data set. J Am Acad Dermatol2006;55:413–21.
60.
AndíaJFDerenSRoblesRRKangSYColónHMOliver-VelezD. Factors associated with injection and noninjection drug use during incarceration among Puerto Rican drug injectors in New York and Puerto Rico. Prison J2005;85:329–42.
61.
DelageGInfante-RivardCChiavettaJWilliemsBPiDFastM. Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study. Gastroenterology1999;116:893–9.
62.
WoodELiKSmallWMontanerJSScheterMTKerrT. Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep2005;120:150–6.
63.
WesternBKlingJRWeimanD. The labor market consequences of incarceration. Princeton University, Industrial Relations Section working paper 450. Princeton (NJ): Princeton University; 2001.
64.
BushwaySStollMAWeimanDF, editors. Barriers to reentry? The labor market for released prisoners in post-industrial America. New York: Russell Sage Foundation; 2007.
65.
IguchiMYBellJRamchandRNFainT. How criminal system racial disparities may translate into health disparities. J Health Care Poor Underserved2005;16(4Suppl B):48–56.
66.
World Health Organization. Global tuberculosis control 2009: Epidemiology, strategy, financing. Geneva: WHO; 2009.
67.
LaxminarayanRKleinEDyeCFloydKDarleySAdeyiO. Economic benefit of tuberculosis control. Policy research working paper 4295. Washington: The World Bank; 2007.
SaundersDLOliveDMWallaceSBLacyDLeybaRKendigNE. Tuberculosis screening in the federal prison system: An opportunity to treat and prevent tuberculosis in foreign-born populations. Public Health Rep2001;116:210–8.
72.
HaddadMBWilsonTWIjazKMarksSMMooreM. Tuberculosis and homelessness in the United States, 1994–2003. JAMA2005;293:2762–6.
73.
LuytWFM. Contemporary corrections in South Africa after more than a decade of transformation. Acta Criminologica2008;21:176–95.
74.
MaherDGrzemskaMConinxRReyesH. Guidelines for the control of tuberculosis in prisons. Geneva: WHO; 1998.
75.
MacIntyreCRKendigNKummerLBiragoSGrahamNM. Impact of tuberculosis control measures and crowding on the incidence of tuberculosis infection in Maryland prisons. Clin Infect Dis1997;24:1060–7.
76.
NoeskeJKuabanCAmougouGPiubelloAPouillotR. Pulmonary tuberculosis in the Central Prison of Douala, Cameroon. East Afr Med J2006;83:25–30.
77.
Liang-FentonD. Failing to protect: Food shortages and prison camps in North Korea. Asian Perspect2007;31:47–74.
78.
Laniado-LoborínR. Tuberculosis in correctional facilities: A nightmare without end in sight. Chest2001;119:681–3.
79.
SteenlandKLevineAJSieberKSchultePAzizD. Incidence of tuberculosis infection among New York State prison employees. Am J Public Health1997;87:2012–4.
SpencerSSMortonAR. Tuberculosis surveillance in a state prison system. Am J Public Health1989;79:507–9.
82.
LevyMHButlerTGZhouJ. Prevalence of Mantoux positivity and annual risk of infection for tuberculosis in New South Wales prisoners, 1996 and 2001. N S W Public Health Bull2007;18:119–24.
83.
TurnerSLongshoreDWenzelSDeschenesEGreenwoodPFainT. A decade of drug treatment court research. Subst Use Misuse2002;37:1489–527.
84.
IndermaurDRobertsL. Drug courts in Australia: The first generation. Curr Issues Crim Justice2003;15:136–54.
85.
JonesPR. Expanding the use of non-custodial sentencing options: An evaluation of the Kansas Community Corrections Act. Howard J Crim Just1990;29:114–29.
86.
GathererAMollerLHaytonP. The World Health Organization European Health In Prisons Project after 10 years: Persistent barriers and achievements. Am J Public Health2005;95:1696–700.
AwofesoN. Prison health advocacy and its changing boundaries. Int J Prison Health2008;4:175–83.
89.
BaldryEMcDonnellDMaplestonePPeetersM. Ex-prisoners, homelessness and the state in Australia. Aus NZ J Criminol2006;39:20–33.
90.
HammettTMRobertsCKennedyS. Health-related issues in prisoner reentry. Crime Delinquency2001;47:390–409.
91.
La VigneNGCowanJBrazzellD. Mapping prisoner reentry: An action research guidebook. 2nd ed.Washington: The Urban Institute; 2006.
92.
WilkinsonRPickettK. The spirit level: Why more equal societies almost always do better. London: Penguin; 2009.
93.
Lappi-SeppäläT. Penal policy in Scandinavia. In: TonryM, editor. Crime and justice, volume 36: Crime, punishment, and politics in comparative perspective. Chicago: University of Chicago Press; 2007. p. 217–9.
94.
WilliamsNH. Prison health and the health of the public: Ties that bind. J Correct Health Care2007;13:80–92.
